Abstract
Programmed Cell Death (PCD) is considered to be a pathological form of cell death when mediated by an intracellular program and it balances cell death with survival of normal cells. Pyroptosis, a type of PCD, is induced by the inflammatory caspase cleavage of gasdermin D (GSDMD) and apoptotic caspase cleavage of gasdermin E (GSDME). This review aims to summarize the latest molecular mechanisms about pyroptosis mediated by pore-forming GSDMD and GSDME proteins that permeabilize plasma and mitochondrial membrane activating pyroptosis and apoptosis. We also discuss the potentiality of pyroptosis as a therapeutic target in human diseases. Blockade of pyroptosis by compounds can treat inflammatory disease and pyroptosis activation contributes to cancer therapy.
Highlights
Many disease states are cross-linked with cell death
Pyroptosis is induced by members of the gasdermin superfamily, including GSDMA, GSDMB, GSDMC, gasdermin D (GSDMD) and gasdermin E (GSDME) [25,26,27,28,29,30], of which, GSDMD and GSDME are widely studied in pyroptosis
Pyroptosis is a new form of programmed cell death and has recently been extensively studied in various diseases
Summary
Many disease states are cross-linked with cell death. The Nomenclature Committee on Cell Death make a series of recommendations to systematically classify cell death [1,2]. Programmed Cell Death (PCD) is mediated by specific cellular mechanisms and some signaling pathways are activated in these processes [3]. Autophagy and programmed necrosis are the three main types of PCD [4], and they may jointly determine the fate of malignant tumor cells. Pyroptosis is a form of programmed necrosis and was firstly described in myeloid cells infected by pathogens or bacteria in 1992 [5,6,7]. Pyroptotic death is an inflammatory form of PCD characterized by cellular swelling and rupture, lysis and release of pro-inflammatory molecules such as Interleukin 1β and Interleukin 18 (IL-1β and IL-18) [9,10]. Pyroptotic death is often harmful to normal tissues, it can be beneficial to cancer treatment. We summarize and discuss the potential effects of pyroptosis in inflammatory diseases and anticancer therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have